Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 6 (2009), Issue 9 (September)

1. Is 'bipolar disorder' the brain's autopoietic response to schizophrenia?
   Med Hypotheses, 73(4): 580-4. [Abstract] [Full-text]
2. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis.
   Br J Psychiatry, 195(3): 194-201. [Abstract] [Full-text]
3. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study.
   J Affect Disord, 117(3): 208-11. [Abstract] [Full-text]
4. Efficacy of high frequency (rapid) suprathreshold repetitive transcranial magnetic stimulation of right prefrontal cortex in bipolar mania: a randomized sham controlled study.
   J Affect Disord, 117(3): 146-50. [Abstract] [Full-text]
5. Factors associated with pain interference in an epidemiologic sample of adults with bipolar I disorder.
   J Affect Disord, 117(3): 151-6. [Abstract] [Full-text]
6. Adult outcomes of youth irritability: a 20-year prospective community-based study.
   Am J Psychiatry, 166(9): 1048-54. [Abstract] [Full-text]
7. Are psychostimulants a treatment option in mania?
   Pharmacopsychiatry, 42(5): 169-74. [Abstract] [Full-text]
8. A comparison of the life goals program and treatment as usual for individuals with bipolar disorder.
   Psychiatr Serv, 60(9): 1182-9. [Abstract] [Full-text]
9. Off-label use of antipsychotic medications in the department of Veterans Affairs health care system.
   Psychiatr Serv, 60(9): 1175-81. [Abstract] [Full-text]
10. Managing bipolar disorders in children and adolescents.
    Nat Rev Neurol, 5(9): 484-91. [Abstract] [Full-text]
11. Dissociable brain structural changes associated with predisposition, resilience, and disease expression in bipolar disorder.
    J Neurosci, 29(35): 10863-8. [Abstract] [Full-text]
12. Successful electroconvulsive therapy in a patient with intellectual disability and bipolar disorder, with catatonic features misdiagnosed as encephalopathy.
    J ECT, 25(3): 202-4. [Abstract] [Full-text]
13. Efficacy of electroconvulsive therapy in Fahr disease associated with bipolar psychotic disorder: a case report.
    J ECT, 25(3): 213-5. [Abstract] [Full-text]
14. Clinical outcomes and quality of life in patients submitted to electroconvulsive therapy.
    J ECT, 25(3): 182-5. [Abstract] [Full-text]
15. Animal model of mania induced by ouabain: Evidence of oxidative stress in submitochondrial particles of the rat brain.
    Neurochem Int, 55(7): 491-5. [Abstract] [Full-text]
16. Evaluation of docosahexaenoic acid deficiency as a preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations.
    Prostaglandins Leukot Essent Fatty Acids, 81(2): 223-31. [Abstract] [Full-text]
17. Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trial.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(7): 1147-52. [Abstract] [Full-text]
18. Increased pituitary volume in patients with established bipolar affective disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 33(7): 1245-9. [Abstract] [Full-text]
19. Concomitant antipsychotic prescribing in US outpatient settings.
    Res Social Adm Pharm, 5(3): 234-41. [Abstract] [Full-text]
20. Trends in the Mental Health Act Review Tribunals: a Welsh experience 2004-2008.
    J Forensic Leg Med, 16(7): 375-7. [Abstract] [Full-text]
21. Sexual Dysfunctions and Suicidality in Patients with Bipolar Disorder and Unipolar Depression.
    J Sex Med. [Abstract] [Full-text]
22. Personality trait predictors of bipolar disorder symptoms.
    Psychiatry Res, 169(2): 159-63. [Abstract] [Full-text]
23. Objective assessment of circadian activity and sleep patterns in individuals at behavioural risk of hypomania.
    J Clin Psychol, 65(10): 1071-86. [Abstract] [Full-text]
24. No association between bipolar disorder and syngr1 or synapsin II polymorphisms in the Han Chinese population.
    Psychiatry Res, 169(2): 167-8. [Abstract] [Full-text]
25. No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample.
    Psychiatry Res, 169(2): 164-6. [Abstract] [Full-text]
26. Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI.
    Int J Neuropsychopharmacol, 12(9): 1249-59. [Abstract] [Full-text]
27. Impact of multifamily psychoeducational psychotherapy in treating children aged 8 to 12 years with mood disorders.
    Arch Gen Psychiatry, 66(9): 1013-21. [Abstract] [Full-text]
28. Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study.
    Arch Gen Psychiatry, 66(9): 957-65. [Abstract] [Full-text]
29. Validation of the revised quick cognitive screening test.
    Arch Phys Med Rehabil, 90(9): 1469-77. [Abstract] [Full-text]
30. No association between DGKH and bipolar disorder in a Scandinavian case-control sample.
    Psychiatr Genet, 19(5): 269-72. [Abstract] [Full-text]
31. Lithium suppresses motility and invasivity of v-src-transformed cells by glutathione-dependent activation of phosphotyrosine phosphatases.
    Oncogene, 28(36): 3246-60. [Abstract] [Full-text]
32. Association between the serotonin 2A receptor gene and bipolar affective disorder in an Australian cohort.
    Psychiatr Genet, 19(5): 244-52. [Abstract] [Full-text]
33. Is elevated noradrenaline an aetiological factor in a number of diseases?
    Auton Autacoid Pharmacol, 29(4): 143-56. [Abstract] [Full-text]
34. Selected summaries from the XVI World Congress of Psychiatric Genetics, Osaka, Japan, 11-15 October 2008.
    Psychiatr Genet, 19(5): 219-36. [Abstract] [Full-text]
35. Theory of mind impairment: a distinct trait-marker for schizophrenia spectrum disorders and bipolar disorder?
    Acta Psychiatr Scand, 120(4): 253-64. [Abstract] [Full-text]
36. GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.
    Neuropharmacology, 57(5): 481-95. [Abstract] [Full-text]
37. Overnight versus progressive conversion of multiple daily-dose divalproex to once-daily divalproex extended release: which strategy is better tolerated by adults with intellectual disabilities?
    J Clin Psychopharmacol, 29(5): 492-5. [Abstract] [Full-text]
38. What is hypomania? tetrachoric factor analysis and kernel estimation of DSM-IV hypomanic symptoms.
    J Clin Psychiatry. [Abstract] [Full-text]
39. The BDNF Val66Met polymorphism: relation to familiar risk of affective disorder, BDNF levels and salivary cortisol.
    Psychoneuroendocrinology, 34(9): 1380-9. [Abstract] [Full-text]
40. Executive functioning in schizophrenia: a thorough examination of performance on the Hayling Sentence Completion Test compared to psychiatric and non-psychiatric controls.
    Schizophr Res, 114(1): 84-90. [Abstract] [Full-text]
41. The psychiatric profile of patients with psychogenic excoriation.
    J Am Acad Dermatol, 61(4): 611-3. [Abstract] [Full-text]
42. Validity and reliability of the Hamilton depression rating scale (5 items) for manic and mixed bipolar disorders.
    J Nerv Ment Dis, 197(9): 682-6. [Abstract] [Full-text]
43. Specificities of defense mechanisms in bipolar affective disorder: relations with symptoms and therapeutic alliance.
    J Nerv Ment Dis, 197(9): 675-81. [Abstract] [Full-text]
44. Development and use of a biological rhythm interview.
    J Affect Disord, 118(1): 161-5. [Abstract] [Full-text]
45. Response to ECT in bipolar I, bipolar II and unipolar depression.
    J Affect Disord, 118(1): 55-9. [Abstract] [Full-text]
46. Demonstration of disturbed activity of orbitofrontal pyramidal neurons in depressed patients by the AgNOR staining method.
    J Affect Disord, 118(1): 131-8. [Abstract] [Full-text]
47. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    J Affect Disord, 118(1): 118-23. [Abstract] [Full-text]
48. Global leukocyte DNA methylation is not altered in euthymic bipolar patients.
    J Affect Disord, 118(1): 234-9. [Abstract] [Full-text]
49. Ziprasidone monotherapy in bipolar II depression: an open trial.
    J Affect Disord, 118(1): 205-8. [Abstract] [Full-text]
50. Use of lithium in the adult populations of Denmark, Norway and Sweden.
    J Affect Disord, 118(1): 224-8. [Abstract] [Full-text]
51. Prefrontal cortical and striatal activity to happy and fear faces in bipolar disorder is associated with comorbid substance abuse and eating disorder.
    J Affect Disord, 118(1): 19-27. [Abstract] [Full-text]
52. A study of age at onset and affective temperaments in a Norwegian sample of patients with mood disorders.
    J Affect Disord, 118(1): 229-33. [Abstract] [Full-text]
53. Pediatric bipolar disorder in a Spanish sample: features before and at the time of diagnosis.
    J Affect Disord, 118(1): 39-47. [Abstract] [Full-text]
54. How suicidal bipolar patients are depends on how suicidal ideation is defined.
    J Affect Disord, 118(1): 48-54. [Abstract] [Full-text]
55. The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis.
    J Neural Transm, 116(10): 1193-200. [Abstract] [Full-text]
56. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes.
    J Affect Disord, 118(1): 28-38. [Abstract] [Full-text]
57. Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD.
    J Neural Transm. [Abstract] [Full-text]
58. Validating GSK3 as an in vivo target of lithium action.
    Biochem Soc Trans, 37: 1133-8. [Abstract] [Full-text]
59. Structure-function studies for the panacea, valproic acid.
    Biochem Soc Trans, 37: 1126-32. [Abstract] [Full-text]
60. Valproic acid- and lithium-sensitivity in prs mutants of Saccharomyces cerevisiae.
    Biochem Soc Trans, 37: 1115-20. [Abstract] [Full-text]
61. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
    Biochem Soc Trans, 37: 1110-4. [Abstract] [Full-text]
62. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
    Biochem Soc Trans, 37: 1104-9. [Abstract] [Full-text]
63. Cellular consequences of inositol depletion.
    Biochem Soc Trans, 37: 1099-103. [Abstract] [Full-text]
64. DTI studies of corpus callosum in bipolar disorder.
    Biochem Soc Trans, 37: 1096-8. [Abstract] [Full-text]
65. The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder.
    Biochem Soc Trans, 37: 1090-5. [Abstract] [Full-text]
66. Risk and resilience in bipolar disorder: rationale and design of the Vulnerability to Bipolar Disorders Study (VIBES).
    Biochem Soc Trans, 37: 1085-9. [Abstract] [Full-text]
67. Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine.
    Biochem Soc Trans, 37: 1080-4. [Abstract] [Full-text]
68. Employing multiple models, methods and mechanisms in bipolar disorder research.
    Biochem Soc Trans, 37: 1077-9. [Abstract] [Full-text]
69. Lithium treatment elongates primary cilia in the mouse brain and in cultured cells.
    Biochem Biophys Res Commun, 388(4): 757-62. [Abstract] [Full-text]
70. Diacylglycerol kinase beta promotes dendritic outgrowth and spine maturation in developing hippocampal neurons.
    BMC Neurosci, 10: 99. [Abstract] [Full-text]
71. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.
    J Clin Psychiatry, 70(8): 1078-90. [Abstract] [Full-text]
72. Is psychopharmacologic treatment associated with neuropsychological deficits in bipolar youth?
    J Clin Psychiatry, 70(8): 1178-85. [Abstract] [Full-text]
73. Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use.
    J Clin Psychiatry, 70(8): 1120-7. [Abstract] [Full-text]
74. What have we learned about bipolar disorder from STEP-BD and other practical trials?
    J Clin Psychiatry, 70(8): e30. [Abstract] [Full-text]
75. Bipolar disorder and concurrent psychiatric and medical disorders.
    J Clin Psychiatry, 70(8): e29. [Abstract] [Full-text]
76. Practical lessons from effectiveness trials of care management and psychoeducation for bipolar disorder.
    J Clin Psychiatry, 70(8): e28. [Abstract] [Full-text]
77. Medical monitoring in patients with bipolar disorder: clinical recommendations.
    J Clin Psychiatry, 70(8): e27. [Abstract] [Full-text]
78. Bipolar disorder: diagnostic conundrums and associated comorbidities.
    J Clin Psychiatry, 70(8): e26. [Abstract] [Full-text]
79. Further immunohistochemical characterization of BRD1 a new susceptibility gene for schizophrenia and bipolar affective disorder.
    Brain Struct Funct. [Abstract] [Full-text]
80. Alternative-splicing in the exon-10 region of GABA(A) receptor beta(2) subunit gene: relationships between novel isoforms and psychotic disorders.
    PLoS One, 4(9): e6977. [Abstract] [Full-text]
81. Increased inferior frontal activation during word generation: a marker of genetic risk for schizophrenia but not bipolar disorder?
    Hum Brain Mapp, 30(10): 3287-98. [Abstract] [Full-text]
82. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
    J Psychiatr Res, 43(14): 1175-84. [Abstract] [Full-text]
83. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients.
    J Psychiatr Res, 43(14): 1171-4. [Abstract] [Full-text]
84. Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticity.
    Brain Res, 1293: 76-84. [Abstract] [Full-text]
85. Child Behavior Checklist Juvenile Bipolar Disorder (CBCL-JBD) and CBCL Posttraumatic Stress Problems (CBCL-PTSP) scales are measures of a single dysregulatory syndrome.
    J Child Psychol Psychiatry, 50(10): 1291-300. [Abstract] [Full-text]
86. Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder.
    J Med Econ. [Abstract] [Full-text]
87. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC).
    Eur Psychiatry, 24(6): 412-24. [Abstract] [Full-text]
88. Circadian preference in bipolar disorder.
    Sleep Breath. [Abstract] [Full-text]
89. Weight gain with atypical antipsychotic drugs in bipolar disorder.
    J Psychosoc Nurs Ment Health Serv, 47(9): 11-2. [Abstract] [Full-text]
90. Using biological networks to search for interacting loci in genome-wide association studies.
    Eur J Hum Genet, 17(10): 1231-40. [Abstract] [Full-text]
91. Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse.
    Psychopharmacology (Berl). [Abstract] [Full-text]
92. Olanzapine-Divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    J Clin Psychiatry. [Abstract] [Full-text]
93. Using oral ziprasidone effectively: the food effect and dose-response.
    Adv Ther, 26(8): 739-48. [Abstract] [Full-text]
94. G72/G30 (DAOA) and juvenile-onset mood disorders.
    Am J Med Genet B Neuropsychiatr Genet, 150(7): 1007-12. [Abstract] [Full-text]
95. Family-based association of YWHAH in psychotic bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 150(7): 977-83. [Abstract] [Full-text]
96. Common and rare variants of DAOA in bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 150(7): 960-6. [Abstract] [Full-text]
97. Association studies and gene expression analyses of the DISC1-interacting molecules, pericentrin 2 (PCNT2) and DISC1-binding zinc finger protein (DBZ), with schizophrenia and with bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 150(7): 967-76. [Abstract] [Full-text]
98. Utilization of herbal and nutritional compounds among older adults with bipolar disorder and with major depression.
    Int J Geriatr Psychiatry, 24(10): 1087-93. [Abstract] [Full-text]
99. A narrow and highly significant linkage signal for severe bipolar disorder in the chromosome 5q33 region in Latin American pedigrees.
    Am J Med Genet B Neuropsychiatr Genet, 150(7): 998-1006. [Abstract] [Full-text]
100. Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples.
     Am J Med Genet B Neuropsychiatr Genet, 150(7): 1017-21. [Abstract] [Full-text]
101. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
     Psychiatry Res, 169(3): 220-8. [Abstract] [Full-text]
102. The P300 as a possible endophenotype for schizophrenia and bipolar disorder: Evidence from twin and patient studies.
     Psychiatry Res, 169(3): 212-9. [Abstract] [Full-text]
103. Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment.
     Psychiatry Res, 169(3): 249-52. [Abstract] [Full-text]
104. A new strategy for linkage analysis under epistasis taking into account genetic heterogeneity.
     Hum Hered, 68(4): 231-42. [Abstract] [Full-text]
105. Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells.
     BMC Pharmacol, 9: 10. [Abstract] [Full-text]
106. A psychoneuroendocrinology service.
     Psychother Psychosom, 78(6): 346-51. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.